ADBiotech Co

ADBiotech Co EBIT Margin

The EBIT Margin (Operating Margin) of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is -27.14 %. In the previous year, EBIT Margin (Operating Margin) was -79.13 % — a change of -65.70% (higher).

EBIT Margin

-27.14 %

YoY

-65.70%

Last updated:

EBIT Margin (Operating Margin) of ADBiotech Co is 2025 -27.14 % . EBIT Margin (Operating Margin) of ADBiotech Co was 2024 -79.13 % . It decreases by -65.70% higher compared to the previous year.

ADBiotech Co's operating (EBIT) margin stands at -27.1%, down from -19.3% several years earlier.

The ADBiotech Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-43.97 KRW
Jan 1, 2019
2.65 KRW
Jan 1, 2020
-10.15 KRW
Jan 1, 2021
-19.34 KRW
Jan 1, 2022
-46.45 KRW
Jan 1, 2023
-70.52 KRW
Jan 1, 2024
-79.13 KRW
Jan 1, 2025
-27.14 KRW
The ADBiotech Co EBIT Margin history
YEAREBIT MarginYoY
-27.14 %-65.70%
-79.13 %+12.22%
-70.52 %+51.81%
-46.45 %+140.14%
-19.34 %+90.58%
-10.15 %-483.18%
2.65 %-106.02%
-43.97 %-1,204.27%
3.98 %-115.01%
-26.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

EBIT Margin (Operating Margin) of ADBiotech Co is -27.14 % in 2025.

EBIT Margin (Operating Margin) of ADBiotech Co changed from -79.13 % to -27.14 %, representing a -65.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s ADBiotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — ADBiotech Co

All Key Metrics — ADBiotech Co